Intrabone cord blood transplants -- partially HLA-matched -- in patients with leukemia appear to have better engraftment success levels and fewer incidences of graft-versus-host disease than do intravenous cord blood transplants, according to recent research. The surgical process on the intrabone transplant is more complicated than the intravenous procedure, but researchers say their "data suggest this new route of administration could be effective."

Related Summaries